SHANGHAI, CHINA - NOVEMBER 07: People visit the Gilead Sciences Inc. booth during the 6th China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) on November ...

Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...

KIEV, UKRAINE - 2019/01/16: In this photo illustration, the Edwards Lifesciences Medical device company logo seen displayed on a smartphone. (Photo Illustration by Igor Golovniov/SOPA ...

Cassava Sciences' stock price jumped 15.5% to $27.13, driven by rising short interest, which now accounts for 35.89% of the total float. he company will hold a conference call on August 8 to discuss ...

Exact Sciences stock is down 35% since August 2021, now trading at around $58.75. The second quarter of 2024 (Q2) results beat expectations with revenue growth driven by the Cologuard screening ...

The biotech earned an important fast-track review designation from a major regulator. This should speed the development (and potentially, commercialization) of one of its investigational treatments.

Biotech leader Gilead Sciences GILD made headlines on Wednesday, with its stock spiking nearly 6% after delivering favorable Q4 results yesterday evening. Thanks to its durable drug pipeline for HIV ...